Takeda Ventures, Inc.'s Net Worth
$1.9 Million
Who is Takeda Ventures, Inc.?
Takeda Ventures, Inc. has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include Xilio Therapeutics, Inc., BiomX Inc., Cortexyme, Inc., Calithera Biosciences, Inc., and Day One Biopharmaceuticals, Inc..
SEC CIK
Takeda Ventures, Inc.'s CIK is 0001771657
Past Insider Trading and Trends
2019 was Takeda Ventures, Inc.'s most active year for acquiring shares with 1 total transactions. Takeda Ventures, Inc.'s most active month to acquire stocks was the month of April. 2019 was Takeda Ventures, Inc.'s most active year for disposing of shares, totalling 2 transactions. Takeda Ventures, Inc.'s most active month to dispose stocks was the month of April. 2019 saw Takeda Ventures, Inc. paying a total of $0.00 for 2,679,802 shares, this is the most they've acquired in one year. In 2019 Takeda Ventures, Inc. cashed out on 2,679,802 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.48M |
—
|
—
| 1.48M |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BiomX Inc. (PHGE) Snapshot price: $1.2094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cortexyme, Inc. (QNCX) Snapshot price: $0.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.68M |
—
|
—
| 2.68M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
No matching records found |
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.63% | -297.27K |
$18.49 | -$5,496,869.49 | 6.12M |
Dec 7 - Dec 8
| |||
Form 4
| -1.69% | -110.21K |
$18.10 | -$1,994,529.59 | 6.42M |
Dec 3 - Dec 6
| |||
Form 4
| +0.88% | 57.22K |
—
|
—
| 6.53M |
Nov 24
| |||
No matching records found |